Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Zeo ScientifiX, Inc.
organization5 mentionslast seen Nov 3, 2026
An SEC-reporting, clinical-stage biopharmaceutical company focused on the research, development, and manufacturing of regenerative biologics.
Relationships 15
- Zeo ScientifiX, Inc.employsGeorge Shapiro99% confidence4 sources
- Zeo ScientifiX, Inc.employsIan T. Bothwell99% confidence4 sources
- Pluri Inc.invests inZeo ScientifiX, Inc.99% confidence2 sources
- Zeo ScientifiX, Inc.partners withPluri Inc.99% confidence2 sources
- Zeo ScientifiX, Inc.conforms toQuality Management Systems Certification97% confidence1 source
- Association for the Advancement of Blood & BiotherapiesapprovesZeo ScientifiX, Inc.96% confidence1 source
- Pluri Inc.partners withZeo ScientifiX, Inc.96% confidence1 source
- Zeo ScientifiX, Inc.applies toregenerative medicine93% confidence1 source
- Zeo ScientifiX, Inc.commercializesregenerative medicine product portfolio92% confidence1 source
- Zeo ScientifiX, Inc.implementsthree-dimensional cell-expansion platform90% confidence1 source
- Zeo ScientifiX, Inc.developsregenerative medicine therapy90% confidence1 source
- Pluri Inc.ownsZeo ScientifiX, Inc.90% confidence1 source
- Zeo ScientifiX, Inc.commercializesCellaV aesthetic product line88% confidence1 source
- Zeo ScientifiX, Inc.implementsGeorgia House Bill 127580% confidence1 source
- Zeo ScientifiX, Inc.implementsTennessee House Bill 224680% confidence1 source
Relationship
Zeo ScientifiX, Inc.employsIan T. Bothwell
99% confidence4 supporting mentions
Either name opens that entity’s relationships.
Sources 4
- filingSEC EDGARNov 3, 2026Zeo ScientifiX, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Ian T. Bothwell Chief Executive Officer and Chief Financial Officer
- filingSEC EDGAROct 30, 2026Zeo ScientifiX, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
Ian Bothwell, Chief Executive Officer and Chief Financial Officer
- filingSEC EDGAROct 26, 2026Zeo ScientifiX, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 9.01: Financial Statements and Exhibits
Ian Bothwell, Chief Executive Officer of ZEO ScientifiX
- filingSEC EDGARSep 15, 2026Zeo ScientifiX, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Ian T. Bothwell Chief Executive Officer and Chief Financial Officer